Together, the increased levels of plasma LPS and TDP-43 observed in ALS patients indicate widespread inflammation and suggest that modulation of the inflammatory response may represent an avenue of therapeutic intervention. Here, TARDBP is linked to amyotrophic lateral sclerosis.